Cargando…

Use of dynamic microsimulation to predict disease progression in patients with pneumonia-related sepsis

INTRODUCTION: Sepsis is the leading cause of death in critically ill patients and often affects individuals with community-acquired pneumonia. To overcome the limitations of earlier mathematical models used to describe sepsis and predict outcomes, we designed an empirically based Monte Carlo model t...

Descripción completa

Detalles Bibliográficos
Autores principales: Saka, Görkem, Kreke, Jennifer E, Schaefer, Andrew J, Chang, Chung-Chou H, Roberts, Mark S, Angus, Derek C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206430/
https://www.ncbi.nlm.nih.gov/pubmed/17570835
http://dx.doi.org/10.1186/cc5942
_version_ 1782148470075817984
author Saka, Görkem
Kreke, Jennifer E
Schaefer, Andrew J
Chang, Chung-Chou H
Roberts, Mark S
Angus, Derek C
author_facet Saka, Görkem
Kreke, Jennifer E
Schaefer, Andrew J
Chang, Chung-Chou H
Roberts, Mark S
Angus, Derek C
author_sort Saka, Görkem
collection PubMed
description INTRODUCTION: Sepsis is the leading cause of death in critically ill patients and often affects individuals with community-acquired pneumonia. To overcome the limitations of earlier mathematical models used to describe sepsis and predict outcomes, we designed an empirically based Monte Carlo model that simulates the progression of sepsis in hospitalized patients over a 30-day period. METHODS: The model simulates changing health over time, as represented by the Sepsis-related Organ Failure Assessment (SOFA) score, as a function of a patient's previous health state and length of hospital stay. We used data from patients enrolled in the GenIMS (Genetic and Inflammatory Markers of Sepsis) study to calibrate the model, and tested the model's ability to predict deaths, discharges, and daily SOFA scores over time using different algorithms to estimate the natural history of sepsis. We evaluated the stability of the methods using bootstrap sampling techniques. RESULTS: Of the 1,888 patients originally enrolled, most were elderly (mean age 67.77 years) and white (80.72%). About half (47.98%) were female. Most were relatively ill, with a mean Acute Physiology and Chronic Health Evaluation III score of 56 and Pneumonia Severity Index score of 73.5. The model's estimates of the daily pattern of deaths, discharges, and SOFA scores over time were not statistically different from the actual pattern when information about how long patients had been ill was included in the model (P = 0.91 to 0.98 for discharges; P = 0.26 to 0.68 for deaths). However, model estimates of these patterns were different from the actual pattern when the model did not include data on the duration of illness (P < 0.001 for discharges; P = 0.001 to 0.040 for deaths). Model results were stable to bootstrap validation. CONCLUSION: An empiric simulation model of sepsis can predict complex longitudinal patterns in the progression of sepsis, most accurately by models that contain data representing both organ-system levels of and duration of illness. This work supports the incorporation into mathematical models of disease of the clinical intuition that the history of disease in an individual matters, and represents an advance over several prior simulation models that assume a constant rate of disease progression.
format Text
id pubmed-2206430
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22064302008-01-19 Use of dynamic microsimulation to predict disease progression in patients with pneumonia-related sepsis Saka, Görkem Kreke, Jennifer E Schaefer, Andrew J Chang, Chung-Chou H Roberts, Mark S Angus, Derek C Crit Care Research INTRODUCTION: Sepsis is the leading cause of death in critically ill patients and often affects individuals with community-acquired pneumonia. To overcome the limitations of earlier mathematical models used to describe sepsis and predict outcomes, we designed an empirically based Monte Carlo model that simulates the progression of sepsis in hospitalized patients over a 30-day period. METHODS: The model simulates changing health over time, as represented by the Sepsis-related Organ Failure Assessment (SOFA) score, as a function of a patient's previous health state and length of hospital stay. We used data from patients enrolled in the GenIMS (Genetic and Inflammatory Markers of Sepsis) study to calibrate the model, and tested the model's ability to predict deaths, discharges, and daily SOFA scores over time using different algorithms to estimate the natural history of sepsis. We evaluated the stability of the methods using bootstrap sampling techniques. RESULTS: Of the 1,888 patients originally enrolled, most were elderly (mean age 67.77 years) and white (80.72%). About half (47.98%) were female. Most were relatively ill, with a mean Acute Physiology and Chronic Health Evaluation III score of 56 and Pneumonia Severity Index score of 73.5. The model's estimates of the daily pattern of deaths, discharges, and SOFA scores over time were not statistically different from the actual pattern when information about how long patients had been ill was included in the model (P = 0.91 to 0.98 for discharges; P = 0.26 to 0.68 for deaths). However, model estimates of these patterns were different from the actual pattern when the model did not include data on the duration of illness (P < 0.001 for discharges; P = 0.001 to 0.040 for deaths). Model results were stable to bootstrap validation. CONCLUSION: An empiric simulation model of sepsis can predict complex longitudinal patterns in the progression of sepsis, most accurately by models that contain data representing both organ-system levels of and duration of illness. This work supports the incorporation into mathematical models of disease of the clinical intuition that the history of disease in an individual matters, and represents an advance over several prior simulation models that assume a constant rate of disease progression. BioMed Central 2007 2007-06-14 /pmc/articles/PMC2206430/ /pubmed/17570835 http://dx.doi.org/10.1186/cc5942 Text en Copyright © 2007 Saka et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Saka, Görkem
Kreke, Jennifer E
Schaefer, Andrew J
Chang, Chung-Chou H
Roberts, Mark S
Angus, Derek C
Use of dynamic microsimulation to predict disease progression in patients with pneumonia-related sepsis
title Use of dynamic microsimulation to predict disease progression in patients with pneumonia-related sepsis
title_full Use of dynamic microsimulation to predict disease progression in patients with pneumonia-related sepsis
title_fullStr Use of dynamic microsimulation to predict disease progression in patients with pneumonia-related sepsis
title_full_unstemmed Use of dynamic microsimulation to predict disease progression in patients with pneumonia-related sepsis
title_short Use of dynamic microsimulation to predict disease progression in patients with pneumonia-related sepsis
title_sort use of dynamic microsimulation to predict disease progression in patients with pneumonia-related sepsis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206430/
https://www.ncbi.nlm.nih.gov/pubmed/17570835
http://dx.doi.org/10.1186/cc5942
work_keys_str_mv AT sakagorkem useofdynamicmicrosimulationtopredictdiseaseprogressioninpatientswithpneumoniarelatedsepsis
AT krekejennifere useofdynamicmicrosimulationtopredictdiseaseprogressioninpatientswithpneumoniarelatedsepsis
AT schaeferandrewj useofdynamicmicrosimulationtopredictdiseaseprogressioninpatientswithpneumoniarelatedsepsis
AT changchungchouh useofdynamicmicrosimulationtopredictdiseaseprogressioninpatientswithpneumoniarelatedsepsis
AT robertsmarks useofdynamicmicrosimulationtopredictdiseaseprogressioninpatientswithpneumoniarelatedsepsis
AT angusderekc useofdynamicmicrosimulationtopredictdiseaseprogressioninpatientswithpneumoniarelatedsepsis
AT useofdynamicmicrosimulationtopredictdiseaseprogressioninpatientswithpneumoniarelatedsepsis